Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ligand Pharmaceuticals (LGND) Long-Term Investments: 2010-2024

Historic Long-Term Investments for Ligand Pharmaceuticals (LGND) over the last 13 years, with Dec 2024 value amounting to $10.9 million.

  • Ligand Pharmaceuticals' Long-Term Investments rose 454.51% to $106.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $106.7 million, marking a year-over-year increase of 454.51%. This contributed to the annual value of $10.9 million for FY2024, which is 70.30% down from last year.
  • Latest data reveals that Ligand Pharmaceuticals reported Long-Term Investments of $10.9 million as of FY2024, which was down 70.30% from $36.7 million recorded in FY2023.
  • Over the past 5 years, Ligand Pharmaceuticals' Long-Term Investments peaked at $375.0 million during FY2021, and registered a low of $3.0 million during FY2022.
  • For the 3-year period, Ligand Pharmaceuticals' Long-Term Investments averaged around $16.9 million, with its median value being $10.9 million (2024).
  • Per our database at Business Quant, Ligand Pharmaceuticals' Long-Term Investments plummeted by 99.20% in 2022 and then spiked by 1,124.20% in 2023.
  • Over the past 4 years, Ligand Pharmaceuticals' Long-Term Investments (Yearly) stood at $375.0 million in 2021, then crashed by 99.20% to $3.0 million in 2022, then skyrocketed by 1,124.20% to $36.7 million in 2023, then tumbled by 70.30% to $10.9 million in 2024.